A detailed history of Davidson Investment Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Davidson Investment Advisors holds 287,537 shares of BMY stock, worth $16.6 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
287,537
Previous 274,542 4.73%
Holding current value
$16.6 Million
Previous $11.4 Million 30.51%
% of portfolio
0.73%
Previous 0.6%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $515,381 - $672,491
12,995 Added 4.73%
287,537 $14.9 Million
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $186,397 - $245,396
4,631 Added 1.72%
274,542 $11.4 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $882,879 - $1 Million
18,401 Added 7.32%
269,911 $14.6 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $311,968 - $372,264
-6,435 Reduced 2.49%
251,510 $12.9 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $345,313 - $386,114
5,965 Added 2.37%
257,945 $15 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $2.63 Million - $2.92 Million
41,270 Added 19.59%
251,980 $16.1 Million
Q1 2023

Aug 22, 2023

SELL
$65.71 - $74.53 $2.71 Million - $3.08 Million
-41,270 Reduced 16.38%
210,710 $14.6 Million
Q1 2023

May 02, 2023

BUY
$65.71 - $74.53 $1.35 Million - $1.54 Million
20,614 Added 10.84%
210,710 $14.6 Million
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $252,074 - $298,492
3,681 Added 1.97%
190,096 $13.7 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $983 - $581,525
7,568 Added 4.23%
186,415 $13.3 Million
Q2 2022

Jul 27, 2022

BUY
$72.62 - $79.98 $132,967 - $146,443
1,831 Added 1.03%
178,847 $13.8 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $192,125 - $230,375
3,125 Added 1.8%
177,016 $12.9 Million
Q4 2021

Jan 28, 2022

SELL
$53.63 - $62.52 $180,733 - $210,692
-3,370 Reduced 1.9%
173,891 $10.8 Million
Q3 2021

Nov 03, 2021

BUY
$59.17 - $69.31 $372,711 - $436,583
6,299 Added 3.68%
177,261 $10.5 Million
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $130,072 - $141,649
-2,101 Reduced 1.21%
170,962 $11.4 Million
Q1 2021

May 07, 2021

BUY
$59.34 - $66.74 $348,681 - $392,164
5,876 Added 3.51%
173,063 $10.9 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $104,220 - $118,101
-1,805 Reduced 1.07%
167,187 $10.4 Million
Q3 2020

Nov 02, 2020

SELL
$57.43 - $63.64 $19,928 - $22,083
-347 Reduced 0.2%
168,992 $10.2 Million
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $2.19 Million - $2.56 Million
39,910 Added 30.84%
169,339 $9.96 Million
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $246,291 - $357,918
-5,308 Reduced 3.94%
129,429 $7.21 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $6.63 Million - $8.65 Million
134,737 New
134,737 $8.65 Million
Q3 2017

Nov 09, 2017

SELL
$55.23 - $63.74 $123,715 - $142,777
-2,240 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
2,240
2,240 $124,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Davidson Investment Advisors Portfolio

Follow Davidson Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Investment Advisors with notifications on news.